Offstream
news

---

Changes

1. Panama authorizes the Pfizer–BioNTech vaccine for people aged 12.
   2021-07-13 03:06:13 (First version)
2. Panama authorizes the Pfizer–BioNTech vaccine for people ages 12 years and over.
   2021-07-20 00:29:08 (Update)
3. Panama authorizes the Pfizer–BioNTech vaccine for people aged 12 years and over.
   (Current version)

---

Related

The European Medicines Agency recommends the usage of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for teenagers over the age of 12 years and also approves the use of the Moderna COVID-19 vaccine for children between the ages of 6 and 11 years.
2022-02-24

The South African Health Products Regulatory Authority approves the Pfizer-BioNTech COVID-19 vaccine booster dose for people over the age of 18 that can be administered six months after their second dose, as well as immunocompromised people aged above 12 years that can be administered 28 days after their second dose.
2021-12-8

Health Canada authorizes the use of booster doses of the Pfizer–BioNTech COVID-19 vaccine for people over the age of 18.
2021-11-9

The Italian Medicines Agency recommends that anyone that received the Janssen COVID-19 vaccine should receive a booster dose of either the Pfizer or Moderna vaccines six months after they received their first dose due to a slow decline of efficacy against mild and moderate forms of the disease.
2021-11-3

Bahrain's National Health Regulatory Authority approves the emergency use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years old.
2021-11-2

The Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for people over the age of 18 years old, which can be administered at least six months after the second dose.
2021-10-27

Panama approves the usage of the Pfizer-BioNTech COVID-19 vaccine as booster for high-risk people, including healthcare workers, bedridden residents, nursing home residents, and people aged over 55.
2021-10-12

The FDA announces its approval for measures allowing the Pfizer–BioNTech COVID-19 vaccine to be stored at regular refrigerator temperatures for up to 30 days before administration. Previously, the agency had only allowed such storage for five days.
2021-05-20

The Therapeutic Goods Administration approves the Pfizer–BioNTech vaccine for use in Australia.
2021-01-25

Panama's Ministry of Health reports a total of 989 cases of COVID-19 in the country, of which 24 people have died.
2020-03-30